Agreed, everyone should remember that Ph1's primary goal is to demonstrate safety, and identify the recommended phase 2 dose. Any hints of efficacy in this trial are a bonus but the absence of any efficacy signal should not dissuade anyone either, especially in the lower dose cohorts
RAC Price at posting:
$1.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)